These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14707284)

  • 1. Cell cycle regulatory functions of the human oncoprotein MDM2.
    Deb SP
    Mol Cancer Res; 2003 Dec; 1(14):1009-16. PubMed ID: 14707284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and dysfunction of the human oncoprotein MDM2.
    Deb SP
    Front Biosci; 2002 Jan; 7():d235-43. PubMed ID: 11779693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2, an introduction.
    Iwakuma T; Lozano G
    Mol Cancer Res; 2003 Dec; 1(14):993-1000. PubMed ID: 14707282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis.
    Brown DR; Thomas CA; Deb SP
    EMBO J; 1998 May; 17(9):2513-25. PubMed ID: 9564034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
    Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
    Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.
    Jones SN; Roe AE; Donehower LA; Bradley A
    Nature; 1995 Nov; 378(6553):206-8. PubMed ID: 7477327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-independent functions of MDM2.
    Ganguli G; Wasylyk B
    Mol Cancer Res; 2003 Dec; 1(14):1027-35. PubMed ID: 14707286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells.
    Dilla T; Velasco JA; Medina DL; González-Palacios JF; Santisteban P
    Endocrinology; 2000 Jan; 141(1):420-9. PubMed ID: 10614665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth arrest function of the human oncoprotein mouse double minute-2 is disabled by downstream mutation in cancer cells.
    Zhou R; Frum R; Deb S; Deb SP
    Cancer Res; 2005 Mar; 65(5):1839-48. PubMed ID: 15753382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mdm2, p53 and the cell cycle: when well enough is best left alone].
    Maréchal V
    Pathol Biol (Paris); 1997 Dec; 45(10):824-32. PubMed ID: 9769946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of MDM2-mediated growth arrest.
    Frum R; Deb SP
    Methods Mol Biol; 2003; 234():257-67. PubMed ID: 12824538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Oliner JD; Pietenpol JA; Thiagalingam S; Gyuris J; Kinzler KW; Vogelstein B
    Nature; 1993 Apr; 362(6423):857-60. PubMed ID: 8479525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of a gene encoding a p53-associated protein in human sarcomas.
    Oliner JD; Kinzler KW; Meltzer PS; George DL; Vogelstein B
    Nature; 1992 Jul; 358(6381):80-3. PubMed ID: 1614537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
    Xiao ZX; Chen J; Levine AJ; Modjtahedi N; Xing J; Sellers WR; Livingston DM
    Nature; 1995 Jun; 375(6533):694-8. PubMed ID: 7791904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.
    Wasylyk C; Salvi R; Argentini M; Dureuil C; Delumeau I; Abecassis J; Debussche L; Wasylyk B
    Oncogene; 1999 Mar; 18(11):1921-34. PubMed ID: 10208414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the p53 regulator murine double-minute protein 2 in rheumatoid arthritis.
    Taranto E; Xue JR; Lacey D; Hutchinson P; Smith M; Morand EF; Leech M
    J Rheumatol; 2005 Mar; 32(3):424-9. PubMed ID: 15742432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdm2 in the response to radiation.
    Perry ME
    Mol Cancer Res; 2004 Jan; 2(1):9-19. PubMed ID: 14757841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
    Meng RD; Shih H; Prabhu NS; George DL; el-Deiry WS
    Clin Cancer Res; 1998 Jan; 4(1):251-9. PubMed ID: 9516979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of the RING finger domain of MDM2 to cell cycle progression.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.